Related by context. Frequent words. (Click for all words.) 64 VEGFR2 inhibitor 63 liposomal formulation 62 2 methoxyestradiol 61 By XiaoBing #-#-# 61 By KEVIN MORAN 61 R sorafenib tablets 61 Sapacitabine 61 metformin sulfonylurea 60 Vytorin combines 60 By Jacob Nthoiwa 60 multi kinase inhibitor 59 By DEEPA BHARATH 59 Xanafide 59 refractive optical elements 59 balbach@dailynewsgroup.com 59 kpender@sfchronicle.com 59 Completes Patient Enrollment 58 By RYAN DEZEMBER 58 Panzem R NCD 58 refractory chronic lymphocytic 58 peripherally acting 58 By Laurie Kulikowski 58 By NANCY SARNOFF 58 WILL NOT BE REFUNDED 58 BY BILL LAITNER 58 ARBULĂ 58 INTEREST AFFILIATE FIREWALL COMPLIANCE 58 By KURT BRESSWEIN 58 investigational oral 58 Initiates Phase II 57 micro optical subassemblies 57 CHEAP ONLINE PHARMACY LOW 57 By KEN HOFFMAN 57 CONDUCT CONFIDENTIALITY CONFLICTS OF 57 OR REVISE ANY FORWARD 57 IN ANY TRANSCRIPT 57 Regulatory Disclosure 57 By GEORGE KING 57 By Nicola Mawson 57 BY JOSHUA ROBIN 57 BMS # 57 docetaxel chemotherapy 57 superwide digital inkjet printers 57 AEG# 56 By SHANNON TOMPKINS 56 BY BILL SALISBURY 56 Am J Obstet 56 HMG CoA reductase inhibitors 56 TRANSLATION INTO GERMAN LANGUAGE 56 By RUTH RENDON 56 By MEGAN MANFULL 56 J Am Coll 56 MADE BASED UPON 56 Acetate Rectal Suppositories 56 Phase Ib clinical trials 56 By PURVA PATEL 56 J Am Acad 56 ANY RESPONSIBILITY FOR ANY 56 AND THE COMPANY 56 Entereg R 56 Visit www.otc advisors.com 56 approvals revisions mgmt 55 By ADAM BRYANT 55 PIG VIRUS THEY SHOULD 55 Regul Integr Comp Physiol 55 PRT# 55 Inhalation Aerosol 55 READ THE DEFINITIVE 55 By MARK CARREAU 55 Phase Ib IIa 55 Receives Orphan Drug Designation 55 AND CONDITIONS OF 55 Completes Enrollment 55 PRICE GREAT DISCOUNT FREE 55 angiotensin receptor blocker ARB 55 By REBECCA WOLF 55 cows boners #-# 55 sunitinib malate 55 DOES SEEKING ALPHA ASSUME 55 Exercise Barrier Barrier 55 By KAREN VOYLES 55 Tekamlo 55 pegylated interferon alfa 2a 54 J Am Soc 54 Amrubicin 54 Lubiprostone 54 interferon gamma 1b 54 Palifosfamide 54 IS FOR INFORMATIONAL 54 Meets Primary Endpoint 54 phase IIb clinical 54 JAK inhibitor 54 generation proteasome inhibitor 54 neutropenia thrombocytopenia 54 REGN# 54 By OLIVER MOORE 54 THE INFORMATION PROVIDED 54 Initiate Phase 54 Phase Ib II 54 HGS ETR2 54 rheumatoid arthritis psoriatic arthritis